Amplifold

Amplifyer Bio

This company develops humanised priming agents that increase circulating tumour DNA recovery to improve liquid biopsy sensitivity for cancer diagnostic providers.

Palamedrix

This company develops DNA nanotechnology and biosensor platforms for multi-omic detection and proteomic analysis for biopharmaceutical and academic research markets.

Dropworks

This company develops digital PCR instruments for highly sensitive nucleic acid quantification for life science and diagnostic researchers.

Anvil Diagnostics

This company develops molecular blood tests to identify and quantify pathogens in hospitalised patients using digital PCR hardware.

Genetic Sequencing

This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.

Amplified Sciences

This company develops molecular diagnostic tests and sensing platforms to help clinicians detect and monitor pancreatic cancer and other serious diseases in patients.

Single molecule diagnostics

This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.

AMiLion AB

This company develops a nanopore-based sensor platform that measures bioavailable copper levels in body fluids for patients with Alzheimer's, Wilson's, and Menkes diseases.